Cytori to Webcast Fourth Quarter and 2018 Financial Results on April 1
March 29 2019 - 8:00AM
Cytori Therapeutics, Inc. (NASDAQ: CYTX) will provide a live
webcast of its fourth quarter and year-end financial results and
business update on Monday, April 1, 2019 at 8:30 AM Eastern Time.
The dial-in information is as
follows: |
|
Dial-In Number: +1.877.402.3914 |
|
Conference ID: 9699923 |
Prior to the webcast at approximately 8:15 AM Eastern Time on
April 1, Cytori will issue its fourth quarter earnings release
which will review Cytori’s third quarter and 2018 annual
performance. The webcast will be available both live and by
replay two hours after the call in the “Webcasts” section of the
company’s investor relations website.
About Cytori Therapeutics, Inc.
Cytori is developing, manufacturing, and commercializing
nanoparticle-delivered oncology drugs and autologous
adipose-derived regenerative cell (ADRC) therapies within its
Nanomedicine™ and Cell Therapy™ franchises, respectively. Cytori
Nanomedicine™ is focused on the liposomal encapsulation of
anti-neoplastic chemotherapy agents, which may enable the effective
delivery of the agents to target sites while reducing systemic
toxicity. The Cytori Nanomedicine™ product pipeline consists of
ATI-0918 pegylated liposomal doxorubicin hydrochloride for breast
cancer, ovarian cancer, multiple myeloma, and Kaposi’s sarcoma, a
complex/hybrid generic drug, and ATI-1123 patented
albumin-stabilized pegylated liposomal docetaxel for multiple solid
tumors. Cytori Cell Therapy™, prepared within several hours with
the proprietary Celution® System and administered to the patient
the same day, has been shown in preclinical and clinical studies to
act principally by improving blood flow, modulating the immune
system, and facilitating wound repair. As a result, Cytori Cell
Therapy™ may provide benefits across multiple disease states and
can be made available to the physician and patient at the
point-of-care. For more information, visit www.cytori.com.
Cytori Therapeutics, Inc.Tiago Girao,
1.858.458.0900ir@cytori.com
Cytori Therapeutics (NASDAQ:CYTX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Cytori Therapeutics (NASDAQ:CYTX)
Historical Stock Chart
From Sep 2023 to Sep 2024